LDHA and neoplasm: Treatment with gossypol, an inhibitor of ALDH, reduced oxphos in the resistant lines in vitro while the combination of gossypol, irinotecan, and phenformin (Complex I inhibitor) synergistically reduced tumor size in therapy naive cells in vivo (Lee et al., 2020).